The latest report published by IMARC Group, titled “Single-Use Bioprocessing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on single-use bioprocessing market research. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global single-use bioprocessing market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.5 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032.
Single-use bioprocessing is a revolutionary approach in the biopharmaceutical manufacturing sector, characterized by the employment of disposable components and systems for the production of biopharmaceuticals. This method encompasses a range of products, such as single-use bioreactors, disposable filters, tubing, connectors, and mixers. These products are specifically designed for one-time usage, thereby eliminating the need for extensive cleaning and sterilization processes, which are pivotal in traditional bioprocessing. Key attributes of single-use bioprocessing systems include enhanced flexibility, scalability, and reduced risk of cross-contamination, making them highly suitable for a variety of biomanufacturing applications.
These systems are acclaimed for their cost-effectiveness, as they significantly reduce capital investments and operational costs associated with cleaning and maintenance. Additionally, single-use bioprocessing is eco-friendly, reducing water and energy usage. The adaptability of these systems to various production volumes, from small-scale clinical batches to full-scale commercial manufacturing, along with their ability to maintain product integrity, positions them as a crucial innovation in the rapidly evolving biopharmaceutical landscape.
Request to Get the Sample Report: https://www.imarcgroup.com/single-use-bioprocessing-market/requestsample
Market Trends:
The global single-use bioprocessing market is witnessing substantial growth, driven by the expanding biopharmaceutical industry and the increasing demand for biologics and biosimilars. This can be supported by the need for more efficient and cost-effective biomanufacturing solutions, which single-use bioprocessing systems adeptly provide. Along with this, the escalating shift towards personalized medicine and the growing emphasis on flexibility and speed in drug development are also propelling the market forward. As biopharmaceutical companies continue to focus on reducing production timelines and ensuring product quality, the adoption of single-use bioprocessing technologies is becoming increasingly prevalent. In addition, advancements in bioprocessing technologies, including automation and integration with upstream and downstream processes, are further enhancing the appeal of single-use systems.
Moreover, the ongoing COVID-19 pandemic is influencing the need for rapid vaccine development and production, where single-use bioprocessing systems are playing a pivotal role. Apart from this, the environmental benefits associated with single-use systems, such as reduced water and energy consumption, align with the growing global focus on sustainable manufacturing practices. Therefore, this is significantly supporting the market. In confluence with this, regulatory support for innovative manufacturing practices and the expansion of biopharmaceutical production capabilities in emerging markets are contributing to the market growth. Furthermore, the introduction of advanced materials and designs for single-use components, offering improved durability and performance, is creating a positive market outlook. Some of the other factors driving the market include rapid industrialization, changing consumer preferences, and inflating disposable income levels of individuals.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/single-use-bioprocessing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Applikon Biotechnology
- Boehringer Ingelheim
- Cesco Bioengineering Company
- Corning Inc.
- Danaher Corporation
- Entegris
- Eppendorf AG
- Finesse Solutions Inc.
- GE Healthcare
- Infors
- Merck Millipore
- Rentschler Biotechnologie
- Sartorius Stedim Biotech
- Thermo Fisher Scientific Inc.
- 3M Company
Single-Use Bioprocessing Market Segmentation:
Our report has categorized the market based on region, product type, application, end-use and end-user.
Product Type Insights:
- Media Bags and Containers
- Filtration Assemblies
- Single-Use Bioreactors
- Disposable Mixers
- Others
Application Insights:
- Filtration
- Storage
- Cell Culture
- Mixing
- Purification
End-Use Insights:
- Upstream
- Fermentation
- Downstream
End-User Insights:
- Biopharmaceutical Manufacturers
- Life Science R&D
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163